Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neuro-ophthalmology

Why Do ADOA Symptoms Vary in Severity Within Families?

At a Glance

ADOA symptoms vary within families due to variable expressivity. While relatives may share the exact same OPA1 gene mutation, differences in overall genetics, mitochondrial health, and lifestyle factors like smoking or medication use can cause vision loss to be milder or more severe.

It can be incredibly confusing to discover that your vision is vastly different—whether significantly worse or much milder—than a parent or sibling who carries the exact same genetic mutation for Autosomal Dominant Optic Atrophy (ADOA). In genetics, this phenomenon is called variable expressivity. It means that even though a family shares the identical primary mutation—usually in the OPA1 gene—the resulting symptoms can range from very mild to severely disabling [1][2]. In some cases, a parent might carry the mutation but have entirely normal vision, a related concept known as incomplete penetrance.

While the OPA1 mutation sets the stage for ADOA, the final severity of your vision loss is shaped by a complex mix of your unique genetic background, your overall mitochondrial health, and the environment you live in. If you are experiencing faster progression than a relative, it is crucial not to blame yourself. Genetics play the heaviest role, and many factors are entirely outside your control.

The Role of Secondary Genetics

You inherit half of your DNA from each parent. Even if you inherited the OPA1 mutation from one parent, you inherited thousands of other genes from both parents. These other genes act as “modifiers,” meaning they can either help compensate for the damaged OPA1 gene or make its effects worse [1][3].

Because every person’s genetic combination is unique, your overall genetic background may provide a different level of support for your optic nerve than your parent’s genetics did. Additionally, ADOA is a disease that affects the mitochondria (the energy factories of your cells). Variations in your specific mitochondrial DNA—which is inherited entirely from your mother—can also influence how well your cells cope with the OPA1 mutation [4].

Environmental and Lifestyle Stressors

The OPA1 gene is responsible for keeping your mitochondria healthy and producing enough energy for your retinal ganglion cells (the cells in your eye that make up the optic nerve) [5][6]. Because these cells are already running on a compromised energy supply, they are highly sensitive to external stress.

If you are exposed to mitochondrial stressors, your vision may deteriorate faster than a relative who avoided those same triggers. Known stressors include:

  • Toxins and Medications: Certain drugs are toxic to mitochondria. For example, the antibiotic ethambutol can trigger or worsen optic nerve damage in people carrying an OPA1 mutation [7][8].
  • Substance Use: Tobacco smoke and heavy alcohol use create high levels of oxidative stress—essentially chemical wear and tear on your cells. Studies have shown that patients with a history of smoking cigarettes and chronically consuming alcohol often experience more severe vision loss [9][10].

Note: If you used tobacco or alcohol before understanding your genetic vulnerability, do not carry guilt for past choices. Focus instead on the protective changes you can make today.

Biological and Early Life Factors

Research suggests that a person’s physical development and biology also play a role in how ADOA expresses itself. Factors present at birth, such as your gestational age and birth weight, have been linked to the long-term severity of ADOA [11]. This may be because early physiological stress on developing mitochondria sets a baseline for future cellular health.

Furthermore, biological sex and hormonal changes can influence the disease. Some evidence indicates that females may experience more severe visual loss during adolescence and greater thinning of the optic nerve fibers compared to males, pointing to a potential hormonal influence on the optic nerve [12].

The ‘ADOA-Plus’ Spectrum

In some families, the same OPA1 mutation might cause isolated vision loss in one person, but cause ADOA-plus in another [1][13]. ADOA-plus involves the optic nerve but also includes broader systemic symptoms like hearing loss, muscle weakness, or balance issues. The development of these additional symptoms is another form of variable expressivity, likely driven by the systemic failure of mitochondrial energy production intersecting with secondary genetic factors [14][15].

It is important not to panic: ADOA-plus only occurs in a minority of individuals with OPA1 mutations [1]. It is not a guaranteed outcome, but rather a possibility your care team should monitor.

Action Steps to Protect Your Vision

While you cannot change your genetics, you can take control of your environmental factors to support your remaining vision:

  • Inform Every Doctor: Always remind your prescribing doctors and pharmacists that you have a “mitochondrial condition” before starting any new medication, and ask them to check for mitochondrial toxicity.
  • Eliminate Stressors: Stop smoking and limit alcohol consumption to reduce the oxidative stress burden on your optic nerve cells.
  • Stay Monitored: Keep up with regular neuro-ophthalmology visits to track your vision and monitor for any emerging signs of ADOA-plus, like hearing changes.

Common questions in this guide

Why is my ADOA worse than my parent's if we have the same mutation?
Even with the exact same OPA1 mutation, your overall genetic background and mitochondrial health are unique. Other modifying genes inherited from your parents and environmental factors can make the effects of the primary mutation more severe or much milder.
Can lifestyle choices make ADOA vision loss progress faster?
Yes. Factors that cause stress to your mitochondria, like smoking tobacco, heavy alcohol use, or certain medications, can worsen optic nerve damage. Stopping smoking and limiting alcohol can reduce oxidative stress and help protect your remaining vision.
What is ADOA-plus and will I get it?
ADOA-plus happens when the condition affects more than just vision, potentially causing hearing loss, muscle weakness, or balance issues. It only occurs in a minority of people with an OPA1 mutation, so it is a possibility to monitor for rather than a guaranteed outcome.
Are there medications I should avoid if I have ADOA?
Because ADOA affects mitochondrial health, you should be cautious with drugs that are known to be toxic to mitochondria, such as the antibiotic ethambutol. Always remind your doctor and pharmacist that you have a mitochondrial condition before starting any new prescriptions.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are there any specific medications or antibiotic families I must avoid to protect my remaining vision?
  2. 2.Should I undergo a baseline hearing test or neurological exam to monitor for ADOA-plus symptoms?
  3. 3.Does my genetic test report show any secondary mutations in other mitochondrial genes that could be influencing my symptoms?
  4. 4.Are there metabolic supplements or lifestyle changes aimed at supporting mitochondrial health that might be appropriate for my specific case?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.

    Ham M, Han J, Osann K, et al.

    Mitochondrion 2019; (46()):262-269 doi:10.1016/j.mito.2018.07.006.

    PMID: 30165240
  2. 2

    Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.

    Chun BY, Rizzo JF

    Seminars in pediatric neurology 2017; (24(2)):129-134 doi:10.1016/j.spen.2017.06.001.

    PMID: 28941528
  3. 3

    Contrasting pathophysiological mechanisms of OPA1 mutations in autosomal dominant optic atrophy.

    Yao SQ, Liang JJ, Zhou H, et al.

    Cell death discovery 2025; (11(1)):259 doi:10.1038/s41420-025-02442-8.

    PMID: 40447565
  4. 4

    OPA1 and disease-causing mutants perturb mitochondrial nucleoid distribution.

    Macuada J, Molina-Riquelme I, Vidal G, et al.

    Cell death & disease 2024; (15(11)):870 doi:10.1038/s41419-024-07165-9.

    PMID: 39616197
  5. 5

    Sustained intracellular calcium rise mediates neuronal mitophagy in models of autosomal dominant optic atrophy.

    Zaninello M, Palikaras K, Sotiriou A, et al.

    Cell death and differentiation 2022; (29(1)):167-177 doi:10.1038/s41418-021-00847-3.

    PMID: 34389813
  6. 6

    Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.

    Formichi P, Radi E, Giorgi E, et al.

    Journal of the neurological sciences 2015; (351(1-2)):99-108 doi:10.1016/j.jns.2015.02.047.

    PMID: 25796301
  7. 7

    Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families.

    Pretegiani E, Rosini F, Rufa A, et al.

    Journal of the neurological sciences 2017; (382()):29-35 doi:10.1016/j.jns.2017.09.018.

    PMID: 29111013
  8. 8

    Mitochondrial Mutations in Ethambutol-Induced Optic Neuropathy.

    Zhang XH, Xie Y, Xu QG, et al.

    Frontiers in cell and developmental biology 2021; (9()):754676 doi:10.3389/fcell.2021.754676.

    PMID: 34676220
  9. 9

    A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family.

    Mei S, Huang X, Cheng L, et al.

    Journal of ophthalmology 2019; (2019()):1424928 doi:10.1155/2019/1424928.

    PMID: 31781369
  10. 10

    Genetic susceptibility to optic neuropathy in patients with alcohol use disorder.

    Delibes C, Ferré M, Rozet M, et al.

    Journal of translational medicine 2024; (22(1)):495 doi:10.1186/s12967-024-05334-0.

    PMID: 38796496
  11. 11

    Visual Function and Inner Retinal Structure in Relation to Birth Factors in Autosomal Dominant Optic Atrophy.

    Eckmann-Hansen C, Bek T, Sander B, Larsen M

    Investigative ophthalmology & visual science 2023; (64(10)):32 doi:10.1167/iovs.64.10.32.

    PMID: 37498569
  12. 12

    Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.

    Sarzi E, Seveno M, Angebault C, et al.

    Human molecular genetics 2016; (25(12)):2539-2551 doi:10.1093/hmg/ddw117.

    PMID: 27260406
  13. 13

    Autosomal dominant optic atrophy plus due to the novel OPA1 variant c.1463G>C.

    Finsterer J, Laccone F

    Metabolic brain disease 2019; (34(4)):1023-1027 doi:10.1007/s11011-019-00425-0.

    PMID: 31152339
  14. 14

    OPA1 mutation affects autophagy and triggers senescence in autosomal dominant optic atrophy plus fibroblasts.

    Zanfardino P, Amati A, Doccini S, et al.

    Human molecular genetics 2024; (33(9)):768-786 doi:10.1093/hmg/ddae008.

    PMID: 38280232
  15. 15

    Biallelic Optic Atrophy 1 (OPA1) Related Disorder-Case Report and Literature Review.

    Othman BA, Ong JE, Dumitrescu AV

    Genes 2022; (13(6)) doi:10.3390/genes13061005.

    PMID: 35741767

This page explains why ADOA symptoms vary for educational purposes. Always consult your neuro-ophthalmologist or genetic counselor to discuss your specific symptoms, genetic test results, and disease progression.

Get notified when new evidence is published on Autosomal dominant optic atrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.